DPP-4 inhibitors (examples: Januvia and Tradjenta) increase IBD risk in Type-2 diabetes patients:
https://www.mdedge.com/clinicalendo...s/dpp-4-inhibitors-increase-ibd-risk-diabetes
https://www.mdedge.com/clinicalendo...s/dpp-4-inhibitors-increase-ibd-risk-diabetes